⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Zucara Therapeutics Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Zucara Therapeutics Inc.
↗Toronto, Canada
Zucara Therapeutics is a diabetes life sciences company focused on developing the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with Type 1 diabetes and insulin-dependent Type 2 diabetes. The company's lead candidate, ZT-01, is designed to inhibit somatostatin, a pancreatic hormone that impairs the body's natural glucagon response to hypoglycemia.
Founded as a spin-off from The Centre for Drug Research and Development (CDRD) and MaRS Innovation, Zucara is headquartered in Toronto, Canada, with additional presence in Vancouver and Montreal. The company is currently advancing its clinical pipeline, supported by strategic investments from organizations including Sanofi, the Perceptive Xontogeny Venture Fund, and the T1D Fund.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$50M+
Investors:Sanofi, The Perceptive Xontogeny Venture Fund (PXV Fund I), T1D Fund, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2a
Modalities:Small molecule, Peptide antagonist
Active Trials:1
Trial Phases:Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Sanofi (Strategic investor and collaborator), JDRF International (Funding and research support), The Leona M. and Harry B. Helmsley Charitable Trust (Funding)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Michael Midmer - CEO
Richard Liggins - Chief Scientific Officer
Susan Peers - Director of Clinical and Regulatory Affairs
Scientific Founders:Dr. Mladen Vranic, Dr. David Coy, Dr. Michael Riddell
LINKS
Website:zucara.ca
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Zucara Therapeutics Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.